Novo Integrated Sciences, Inc. (NVOS)

Market Cap	69.06K -92.6%
Revenue (ttm)	13.29M +5.7%
Net Income	-16.17M
EPS	-0.90
Shares Out	19.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	613
Average Volume	8,450
Open	0.0035
Previous Close	0.0031
Day's Range	0.0035 - 0.0035
52-Week Range	0.0001 - 0.0700
Beta	0.63
RSI	53.93
Earnings Date	Dec 18, 2025

About Novo Integrated Sciences

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Robert Mattacchione
• Employees: 264
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVOS

Financial Performance

In fiscal year 2024, Novo Integrated Sciences's revenue was $13.29 million, an increase of 5.75% compared to the previous year's $12.57 million. Losses were -$16.17 million, 22.3% more than in 2023.